SYNTHESES FOR PRODUCTION OF INOSITOLPHOSPHOLIPIDS

Information

  • Research Project
  • 6526019
  • ApplicationId
    6526019
  • Core Project Number
    R44GM059550
  • Full Project Number
    5R44GM059550-03
  • Serial Number
    59550
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1999 - 25 years ago
  • Project End Date
    8/31/2005 - 19 years ago
  • Program Officer Name
    CHIN, JEAN
  • Budget Start Date
    9/1/2002 - 22 years ago
  • Budget End Date
    8/31/2005 - 19 years ago
  • Fiscal Year
    2002
  • Support Year
    3
  • Suffix
  • Award Notice Date
    8/30/2002 - 22 years ago
Organizations

SYNTHESES FOR PRODUCTION OF INOSITOLPHOSPHOLIPIDS

Description: (Applicant's abstract): Inositolphospholipids are an important group of biological amphiphilic phospholipids. The group includes phosphatidylinositols (PtdIns) and its radyl and sphingo analogues. Members of the group are critical intracellular signaling messengers, and important as biomedical research reagents and for developing diagnostics and therapeutics based on signaling modalities. Furthermore, inositolphospholipids are biocompatible amphiphiles with applications in skin-care and intravenous drug delivery formulations. No practical approach adaptable for economical large scale production is available. The overall objective of this investigation is to develop laboratory scale methods of synthesis, potentially adaptable for economical larger scale production, for preparing individual molecular species of PtdIns and analogous inositolphospholipids. During Phase I, a novel approach, applicable to the entire biological PtdIns group and tailored analogues, was experimentally validated for PtdIns synthesis, and the structural and stereochemical integrity of the products was established unequivocally. During Phase II, this approach to synthesis will be optimized for ultimate economical larger scale production of PtdIns, and extended to radyl, sphingolipid, thiophosphate and phosphonate type analogues and selected diastereomers. Further, the approach will be exploited for the preparation of selected inositolphospholipid molecular species. PROPOSED COMMERCIAL APPLICATION: Not Available

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    302891
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:302891\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NUTRIMED BIOTECH
  • Organization Department
  • Organization DUNS
  • Organization City
    ITHACA
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    14850
  • Organization District
    UNITED STATES